Platelet aggregation response in immune thrombocytopenia patients treated with romiplostim

Romiplostim for the management of perioperative thrombocytopenia

(2018) Hanny Al-Samkari et al.   BRITISH JOURNAL OF HAEMATOLOGY

Relative potency of the thrombopoietin receptor agonists eltrombopag, avatrombopag and romiplostim in a patient with chronic immune thrombocytopenia

(2018) Hanny Al-Samkari et al.   BRITISH JOURNAL OF HAEMATOLOGY

Thrombopoietin level predicts response to treatment with eltrombopag and romiplostim in immune thrombocytopenia

(2018) Hanny Al-Samkari et al.   AMERICAN JOURNAL OF HEMATOLOGY

The use of romiplostim in treating chemotherapy-induced thrombocytopenia in patients with solid tumors

(2017) Hanny Al-Samkari et al.   HAEMATOLOGICA

Bleeding tendency and platelet function during treatment with romiplostim in children with severe immune thrombocytopenic purpura

(2017) Elena V. Suntsova et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

The use of romiplostim in treating chemotherapy-induced thrombocytopenia in patients with solid tumors

(2017) Hanny Al-Samkari et al.   HAEMATOLOGICA

Platelet function in adult ITP patients can be either increased or decreased, compared to healthy controls, and is associated with bleeding risk

(2016) Rutger A. Middelburg et al.   Hematology

Thromboembolism in patients with immune thrombocytopenia (ITP): a meta-analysis of observational studies

(2016) Wendy J. Langeberg et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Platelet function tests, independent of platelet count, are associated with bleeding severity in ITP

(2015) A. L. Frelinger et al.   BLOOD

Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostim

(2015) Douglas B. Cines et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug

(2013) R. Desmond et al.   BLOOD

Eltrombopag Increases Platelet Numbers in Thrombocytopenic Patients With HCV Infection and Cirrhosis, Allowing for Effective Antiviral Therapy

(2013) Nezam H. Afdhal et al.   GASTROENTEROLOGY

Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the platelet physiology subcommittee of SSC/ISTH

(2013) M. Cattaneo et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation

(2012) B. Psaila et al.   BLOOD

Eltrombopag before Procedures in Patients with Cirrhosis and Thrombocytopenia

(2012) Nezam H. Afdhal et al.   NEW ENGLAND JOURNAL OF MEDICINE

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia

(2011) C. Neunert et al.   BLOOD

Risk of venous thromboembolism in patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study

(2010) Marianne T. Severinsen et al.   BRITISH JOURNAL OF HAEMATOLOGY

Influences of antiplatelet autoantibodies on platelet function in immune thrombocytopenic purpura

(2010) Mutsumasa Yanabu et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database

(2010) A. Sarpatwari et al.   HAEMATOLOGICA

Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study

(2010) Gregory Cheng et al.   LANCET

Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia

(2010) David J. Kuter et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparative analyses of the small molecule thrombopoietin receptor agonist eltrombopag and thrombopoietin on in vitro platelet function

(2009) Joseph A. Erhardt et al.   EXPERIMENTAL HEMATOLOGY

Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP

(2008) J. B. Bussel et al.   BLOOD

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

(2008) F. Rodeghiero et al.   BLOOD

Increased procoagulant cell-derived microparticles (C-MP) in splenectomized patients with ITP

(2008) V. Fontana et al.   THROMBOSIS RESEARCH